160 related articles for article (PubMed ID: 17931752)
1. Intradermal administration of DNA vaccines combining a strategy to bypass antigen processing with a strategy to prolong dendritic cell survival enhances DNA vaccine potency.
Huang B; Mao CP; Peng S; He L; Hung CF; Wu TC
Vaccine; 2007 Nov; 25(45):7824-31. PubMed ID: 17931752
[TBL] [Abstract][Full Text] [Related]
2. Cancer immunotherapy using a DNA vaccine encoding a single-chain trimer of MHC class I linked to an HPV-16 E6 immunodominant CTL epitope.
Huang CH; Peng S; He L; Tsai YC; Boyd DA; Hansen TH; Wu TC; Hung CF
Gene Ther; 2005 Aug; 12(15):1180-6. PubMed ID: 15800656
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of DNA vaccine potency through coadministration of CIITA DNA with DNA vaccines via gene gun.
Kim D; Hoory T; Monie A; Ting JP; Hung CF; Wu TC
J Immunol; 2008 May; 180(10):7019-27. PubMed ID: 18453624
[TBL] [Abstract][Full Text] [Related]
4. Innovative DNA vaccine for human papillomavirus (HPV)-associated head and neck cancer.
Wu A; Zeng Q; Kang TH; Peng S; Roosinovich E; Pai SI; Hung CF
Gene Ther; 2011 Mar; 18(3):304-12. PubMed ID: 20981112
[TBL] [Abstract][Full Text] [Related]
5. DNA vaccines for cervical cancer: from bench to bedside.
Hung CF; Monie A; Alvarez RD; Wu TC
Exp Mol Med; 2007 Dec; 39(6):679-89. PubMed ID: 18160838
[TBL] [Abstract][Full Text] [Related]
6. Development of a DNA vaccine targeting human papillomavirus type 16 oncoprotein E6.
Peng S; Ji H; Trimble C; He L; Tsai YC; Yeatermeyer J; Boyd DA; Hung CF; Wu TC
J Virol; 2004 Aug; 78(16):8468-76. PubMed ID: 15280455
[TBL] [Abstract][Full Text] [Related]
7. A DNA vaccine co-expressing antigen and an anti-apoptotic molecule further enhances the antigen-specific CD8+ T-cell immune response.
Kim TW; Hung CF; Zheng M; Boyd DA; He L; Pai SI; Wu TC
J Biomed Sci; 2004; 11(4):493-9. PubMed ID: 15153784
[TBL] [Abstract][Full Text] [Related]
8. Enhancing DNA vaccine potency by coadministration of DNA encoding antiapoptotic proteins.
Kim TW; Hung CF; Ling M; Juang J; He L; Hardwick JM; Kumar S; Wu TC
J Clin Invest; 2003 Jul; 112(1):109-17. PubMed ID: 12840065
[TBL] [Abstract][Full Text] [Related]
9. Comparison of HPV DNA vaccines employing intracellular targeting strategies.
Kim JW; Hung CF; Juang J; He L; Kim TW; Armstrong DK; Pai SI; Chen PJ; Lin CT; Boyd DA; Wu TC
Gene Ther; 2004 Jun; 11(12):1011-8. PubMed ID: 14985791
[TBL] [Abstract][Full Text] [Related]
10. DNA vaccine encoding heat shock protein 60 co-linked to HPV16 E6 and E7 tumor antigens generates more potent immunotherapeutic effects than respective E6 or E7 tumor antigens.
Huang CY; Chen CA; Lee CN; Chang MC; Su YN; Lin YC; Hsieh CY; Cheng WF
Gynecol Oncol; 2007 Dec; 107(3):404-12. PubMed ID: 17905417
[TBL] [Abstract][Full Text] [Related]
11. Enhancing DNA vaccine potency by combining a strategy to prolong dendritic cell life with intracellular targeting strategies.
Kim TW; Hung CF; Boyd D; Juang J; He L; Kim JW; Hardwick JM; Wu TC
J Immunol; 2003 Sep; 171(6):2970-6. PubMed ID: 12960321
[TBL] [Abstract][Full Text] [Related]
12. Characterization of HPV-16 E6 DNA vaccines employing intracellular targeting and intercellular spreading strategies.
Peng S; Trimble C; Ji H; He L; Tsai YC; Macaes B; Hung CF; Wu TC
J Biomed Sci; 2005 Oct; 12(5):689-700. PubMed ID: 16200349
[TBL] [Abstract][Full Text] [Related]
13. Administration of HPV DNA vaccine via electroporation elicits the strongest CD8+ T cell immune responses compared to intramuscular injection and intradermal gene gun delivery.
Best SR; Peng S; Juang CM; Hung CF; Hannaman D; Saunders JR; Wu TC; Pai SI
Vaccine; 2009 Sep; 27(40):5450-9. PubMed ID: 19622402
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of suicidal DNA vaccine potency by delaying suicidal DNA-induced cell death.
Kim TW; Hung CF; Juang J; He L; Hardwick JM; Wu TC
Gene Ther; 2004 Feb; 11(3):336-42. PubMed ID: 14737094
[TBL] [Abstract][Full Text] [Related]
15. Optimal induction of HPV DNA vaccine-induced CD8+ T cell responses and therapeutic antitumor effect by antigen engineering and electroporation.
Seo SH; Jin HT; Park SH; Youn JI; Sung YC
Vaccine; 2009 Sep; 27(42):5906-12. PubMed ID: 19651174
[TBL] [Abstract][Full Text] [Related]
16. Vaccination with a DNA vaccine encoding herpes simplex virus type 1 VP22 linked to antigen generates long-term antigen-specific CD8-positive memory T cells and protective immunity.
Kim TW; Hung CF; Kim JW; Juang J; Chen PJ; He L; Boyd DA; Wu TC
Hum Gene Ther; 2004 Feb; 15(2):167-77. PubMed ID: 14975189
[TBL] [Abstract][Full Text] [Related]
17. Role of IL-2 secreted by PADRE-specific CD4+ T cells in enhancing E7-specific CD8+ T-cell immune responses.
Kim D; Monie A; He L; Tsai YC; Hung CF; Wu TC
Gene Ther; 2008 May; 15(9):677-87. PubMed ID: 18273057
[TBL] [Abstract][Full Text] [Related]
18. Generation and characterization of a preventive and therapeutic HPV DNA vaccine.
Kim D; Gambhira R; Karanam B; Monie A; Hung CF; Roden R; Wu TC
Vaccine; 2008 Jan; 26(3):351-60. PubMed ID: 18096279
[TBL] [Abstract][Full Text] [Related]
19. Enhancing DNA vaccine potency by combining a strategy to prolong dendritic cell life and intracellular targeting strategies with a strategy to boost CD4+ T cell.
Kim D; Hoory T; Wu TC; Hung CF
Hum Gene Ther; 2007 Nov; 18(11):1129-39. PubMed ID: 17939748
[TBL] [Abstract][Full Text] [Related]
20. DNA vaccines employing intracellular targeting strategies and a strategy to prolong dendritic cell life generate a higher number of CD8+ memory T cells and better long-term antitumor effects compared with a DNA prime-vaccinia boost regimen.
Kim TW; Lee JH; He L; Boyd DA; Hung CF; Wu TC
Hum Gene Ther; 2005 Jan; 16(1):26-34. PubMed ID: 15703486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
